BACKGROUND AND PURPOSE: Recent studies have shown that selective regional, but not global, GM atrophy occurs from clinical onset to conversion to clinically definite MS. Our aim was to investigate the difference in the extent of SDGM and cortical atrophy in a large sample of patients with CIS and early RRMS and to explore the relationship between SDGM and cortical atrophy and other MR imaging and clinical outcomes. MATERIALS AND METHODS: Two hundred twelve patients with CIS recruited at the first clinical event (mean age, 29.3 years; median EDSS, 1.5; median disease duration, 3 months) and 177 patients with early RRMS (mean age, 30.7 years; median EDSS, 2.0; median disease duration, 47 months) were imaged on a 1.5T scanner by using a high-resolution 3D T1 spoiled gradient-recalled sequence. Volumetric data for SDGM structures were obtained by using FSL FIRST, while whole-brain, GM, white matter, cortical, and lateral ventricle volumes were estimated by using SIENAX software. Comparisons between the groups were adjusted for age and sex. RESULTS: Patients with early RRMS showed significantly lower SDGM but not cortical volumes compared with patients with CIS. The most apparent SDGM differences were evident in the caudate and thalamus (P < .0001), total SDGM (P = .0001), and globus pallidus (P = .01). Patients with CIS with a median T2 lesion volume >4.49 mL showed lower total SDGM, caudate, thalamus (P < .001), globus pallidus (P = .007), hippocampus (P = .004), and putamen (P = .01) volumes and higher lateral ventricle volume (P = .001) than those with a median T2 lesion volume <4.49 mL. Decreased thalamic volume showed the most consistent relationship with MR imaging outcomes (P < .0001) in patients with CIS. CONCLUSIONS: Significant SDGM, but not cortical, atrophy develops during the first 4 years of the RRMS. GM atrophy is relevant for disease progression from the earliest clinical stages.
BACKGROUND AND PURPOSE: Recent studies have shown that selective regional, but not global, GMatrophy occurs from clinical onset to conversion to clinically definite MS. Our aim was to investigate the difference in the extent of SDGM and cortical atrophy in a large sample of patients with CIS and early RRMS and to explore the relationship between SDGM and cortical atrophy and other MR imaging and clinical outcomes. MATERIALS AND METHODS: Two hundred twelve patients with CIS recruited at the first clinical event (mean age, 29.3 years; median EDSS, 1.5; median disease duration, 3 months) and 177 patients with early RRMS (mean age, 30.7 years; median EDSS, 2.0; median disease duration, 47 months) were imaged on a 1.5T scanner by using a high-resolution 3D T1 spoiled gradient-recalled sequence. Volumetric data for SDGM structures were obtained by using FSL FIRST, while whole-brain, GM, white matter, cortical, and lateral ventricle volumes were estimated by using SIENAX software. Comparisons between the groups were adjusted for age and sex. RESULTS:Patients with early RRMS showed significantly lower SDGM but not cortical volumes compared with patients with CIS. The most apparent SDGM differences were evident in the caudate and thalamus (P < .0001), total SDGM (P = .0001), and globus pallidus (P = .01). Patients with CIS with a median T2 lesion volume >4.49 mL showed lower total SDGM, caudate, thalamus (P < .001), globus pallidus (P = .007), hippocampus (P = .004), and putamen (P = .01) volumes and higher lateral ventricle volume (P = .001) than those with a median T2 lesion volume <4.49 mL. Decreased thalamic volume showed the most consistent relationship with MR imaging outcomes (P < .0001) in patients with CIS. CONCLUSIONS: Significant SDGM, but not cortical, atrophy develops during the first 4 years of the RRMS. GMatrophy is relevant for disease progression from the earliest clinical stages.
Authors: Stefan D Roosendaal; Kerstin Bendfeldt; Hugo Vrenken; Chris H Polman; Stefan Borgwardt; Ernst W Radue; Ludwig Kappos; Daniel Pelletier; Stephen L Hauser; Paul M Matthews; Frederik Barkhof; Jeroen J G Geurts Journal: Mult Scler Date: 2011-05-17 Impact factor: 6.312
Authors: Rajendra A Morey; Christopher M Petty; Yuan Xu; Jasmeet Pannu Hayes; H Ryan Wagner; Darrell V Lewis; Kevin S LaBar; Martin Styner; Gregory McCarthy Journal: Neuroimage Date: 2008-12-30 Impact factor: 6.556
Authors: L K Fisniku; D R Altmann; M Cercignani; D J Tozer; D T Chard; J S Jackson; K A Miszkiel; K Schmierer; A J Thompson; D H Miller Journal: Mult Scler Date: 2009-05-12 Impact factor: 6.312
Authors: J Hodel; O Outteryck; E Ryo; A-L Bocher; O Lambert; D Chéchin; H Zéphir; A Lacour; J-P Pruvo; P Vermersch; X Leclerc Journal: AJNR Am J Neuroradiol Date: 2013-11-07 Impact factor: 3.825
Authors: Kerstin Bendfeldt; Bernd Taschler; Laura Gaetano; Philip Madoerin; Pascal Kuster; Nicole Mueller-Lenke; Michael Amann; Hugo Vrenken; Viktor Wottschel; Frederik Barkhof; Stefan Borgwardt; Stefan Klöppel; Eva-Maria Wicklein; Ludwig Kappos; Gilles Edan; Mark S Freedman; Xavier Montalbán; Hans-Peter Hartung; Christoph Pohl; Rupert Sandbrink; Till Sprenger; Ernst-Wilhelm Radue; Jens Wuerfel; Thomas E Nichols Journal: Brain Imaging Behav Date: 2019-10 Impact factor: 3.978
Authors: Christian Langkammer; Tian Liu; Michael Khalil; Christian Enzinger; Margit Jehna; Siegrid Fuchs; Franz Fazekas; Yi Wang; Stefan Ropele Journal: Radiology Date: 2013-01-11 Impact factor: 11.105
Authors: Martijn D Steenwijk; Marita Daams; Petra J W Pouwels; Lisanne J Balk; Prejaas K Tewarie; Jeroen J G Geurts; Frederik Barkhof; Hugo Vrenken Journal: Hum Brain Mapp Date: 2015-01-27 Impact factor: 5.038
Authors: Rachel Brandstadter; Michelle Fabian; Victoria M Leavitt; Stephen Krieger; Anusha Yeshokumar; Ilana Katz Sand; Sylvia Klineova; Claire S Riley; Christina Lewis; Gabrielle Pelle; Fred D Lublin; Aaron E Miller; James F Sumowski Journal: Mult Scler Date: 2019-11-19 Impact factor: 6.312
Authors: Niels Bergsland; Ferdinand Schweser; Michael G Dwyer; Bianca Weinstock-Guttman; Ralph H B Benedict; Robert Zivadinov Journal: Hum Brain Mapp Date: 2018-06-19 Impact factor: 5.038